1-5 of 5
Authors: Kaylyn Sinicrope
Journal Article
RTID-04. A MULTICENTER, RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE) Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii273, https://doi.org/10.1093/neuonc/noae165.1080
Published: 11 November 2024
Journal Article
SURG-32. EFFICACY OF LASER INTERSTITIAL THERMAL THERAPY (LITT) FOR BIOPSY-PROVEN RADIATION NECROSIS IN RADIOGRAPHICALLY RECURRENT BRAIN METASTASES Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v269, https://doi.org/10.1093/neuonc/noad179.1031
Published: 10 November 2023
Journal Article
SURG-23. EFFICACY OF LASER INTERSTITIAL THERMAL THERAPY (LITT) FOR NEWLY DIAGNOSED AND RECURRENT IDH WILD-TYPE GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii256–vii257, https://doi.org/10.1093/neuonc/noac209.989
Published: 14 November 2022
Journal Article
CTIM-20. PROSPECTIVE RANDOMIZED PHASE II PLACEBO-CONTROLLED TRIAL OF SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA (SURVIVE) Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii64, https://doi.org/10.1093/neuonc/noac209.252
Published: 14 November 2022
Journal Article
INNV-20. ELEVATED INTRACRANIAL PRESSURE WITHOUT HYDROCEPHALUS IN PATIENTS WITH NEUROFIBROMATOSIS 2 Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii120, https://doi.org/10.1093/neuonc/noaa215.503
Published: 09 November 2020
